References
- 1
Kronborg O, Fenger C, Olsen J. et al .
Randomized study as screening for colorectal cancer with faecal-occult-blood test.
Lancet.
1996;
348
1467-1471
- 2
Hardcastle J D, Chamberlain J O, Robinson M HE. et al .
Randomized controlled trial of faecal-occult-blood screening for colorectal cancer.
Lancet.
1996;
348
1472-1477
- 3
Faivre J, Dancourt V, Lejeune C. et al .
Reduction in colorectal cancer mortality by fecal occult blood screening in a controlled
study in France.
Gastroenterology.
2004;
126
1674-1680
- 4
Mandel J S, Bond J H, Church T R. et al .
Reducing mortality from colorectal cancer by screening for faecal occult blood.
N Engl J Med.
1993;
328
1365-1371
- 5
Jouve J L, Remontet L, Dancourt V. et al .
Estimation of screening test (Hemoccult) sensitivity in colorectal cancer mass screening.
Br J Cancer.
2001;
84
1477-1481
- 6
Bertario L, Spinelli P, Gennari L. et al .
Sensitivity of Hemoccult test for large bowel cancer in high-risk subjects.
Dig Dis Sci.
1988;
33
609-613
- 7
Mandel J S, Church T R, Ederer F. et al .
Colorectal cancer mortality: effectiveness of biennial screening for fecal occult
blood.
J Natl Cancer Inst.
1999;
91
434-437
- 8
Mandel J S, Church T R, Bond J H. et al .
The effect of fecal occult-blood screening on the incidence of colorectal cancer.
N Engl J Med.
2000;
343
1603-1607
- 9
Lang C A, Ransohoff D F.
Facal occult blood screening for colorectal cancer: is mortality reduced by chance
selection for screening colonoscopy?.
JAMA.
1994;
271
1011-1013
- 10
Tazi M A, Faivre J, Dassonville F. et al .
Participation in faecal occult blood screening for colorectal cancer in a well defined
French population : results of five screening rounds from 1988 to 1996.
J Med Screening.
1997;
4
147-151
- 11
Morikawa T, Kato J, Yamaji Y. et al .
A comparison of the immunochemical fecal occult blood test and total colonoscopy in
the asymptomatic population.
Gastroenterology.
2005;
129
422-428
- 12
Guittet L, Bouvier V, Mariotte N. et al .
Comparison of a guaiac-based and an immunochemical fecal occult blood test in screening
for colorectal cancer in a general average-risk population.
Gut.
2007;
56
210-214
- 13
Imperiale T F, Rahsohoff D F, Itzkowitz S H. et al .
Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk
population.
N Engl J Med.
2004;
351
2704-2714
Jean Faivre
Hôpital du Bocage, Hépato-Gastroentérologie
2, Bd Mal de Lattre de Tassigny
21034 Dijon Cedex, France
Phone: ++ 33/3/80 29/37 50
Fax: ++ 33/3/80 29/37 22
Email: jean.faivre@chu-dijon.fr
